MX2018012964A - Métodos y composiciones de uso para el tratamiento de la degeneración de tendón. - Google Patents
Métodos y composiciones de uso para el tratamiento de la degeneración de tendón.Info
- Publication number
- MX2018012964A MX2018012964A MX2018012964A MX2018012964A MX2018012964A MX 2018012964 A MX2018012964 A MX 2018012964A MX 2018012964 A MX2018012964 A MX 2018012964A MX 2018012964 A MX2018012964 A MX 2018012964A MX 2018012964 A MX2018012964 A MX 2018012964A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- treating tendon
- tendon degeneration
- treating
- injectable compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/386—Ligaments, tendons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
- Closures For Containers (AREA)
Abstract
Las composiciones inyectables y los metodos para tratar un tendon lesionado en un animal o humano se describen en el presente documento. Las composiciones inyectables incluyen una cantidad eficaz de un carbohidrato para aumentar la hidratacion y lubricacion osteotendinosa.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662328396P | 2016-04-27 | 2016-04-27 | |
US201662367377P | 2016-07-27 | 2016-07-27 | |
PCT/US2017/029635 WO2017189723A1 (en) | 2016-04-27 | 2017-04-26 | Compositions for use in treating tendon degeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018012964A true MX2018012964A (es) | 2019-06-10 |
Family
ID=58709560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018012964A MX2018012964A (es) | 2016-04-27 | 2017-04-26 | Métodos y composiciones de uso para el tratamiento de la degeneración de tendón. |
Country Status (15)
Country | Link |
---|---|
US (1) | US10441677B2 (es) |
EP (1) | EP3448394B1 (es) |
JP (1) | JP6826657B2 (es) |
KR (1) | KR20190009303A (es) |
CN (1) | CN109562124A (es) |
AU (1) | AU2017257956B2 (es) |
CA (1) | CA3021764C (es) |
IL (1) | IL262507B (es) |
MX (1) | MX2018012964A (es) |
NZ (1) | NZ747413A (es) |
RU (1) | RU2018141386A (es) |
SG (2) | SG10201913342UA (es) |
TW (2) | TWI755392B (es) |
WO (1) | WO2017189723A1 (es) |
ZA (1) | ZA201807136B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200368027A1 (en) | 2018-01-02 | 2020-11-26 | Cartiheal (2009) Ltd. | Implantation Tool and Protocol for Optimized Solid Substrates Promoting Cell and Tissue Growth |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2946819A (en) | 1958-04-14 | 1960-07-26 | Gen Aniline & Film Corp | Process of producing carbodimides |
DE1156401B (de) | 1960-05-24 | 1963-10-31 | Bayer Ag | Verfahren zur Herstellung von Carbodiimiden |
DE1149712B (de) | 1961-11-14 | 1963-06-06 | Bayer Ag | Verfahren zur Herstellung von Carbodiimiden |
US3644456A (en) | 1964-08-12 | 1972-02-22 | Upjohn Co | Di((isocyanatobenzyl)-phenyl) carbodiimides and preparation of organic carbodiimides |
US3972933A (en) | 1974-05-28 | 1976-08-03 | Monsanto Company | Preparation of carbodiimides from ureas by dehydration |
GB1476088A (en) | 1975-04-03 | 1977-06-10 | Ici Ltd | Carbodiimides |
DE2556760A1 (de) | 1975-12-17 | 1977-06-30 | Hoechst Ag | Verfahren zur herstellung von carbodiimiden |
GB1584153A (en) | 1976-09-22 | 1981-02-04 | Ici Ltd | Carbodimides |
US4066629A (en) | 1976-10-28 | 1978-01-03 | Celanese Corporation | Process for preparing carbodiimides utilizing a phosphonium salt catalyst |
US4098973A (en) | 1977-01-31 | 1978-07-04 | The Upjohn Company | Compounds and process |
US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
US5356883A (en) | 1989-08-01 | 1994-10-18 | Research Foundation Of State University Of N.Y. | Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
ITPD940054A1 (it) | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
ATE229038T1 (de) | 1997-04-04 | 2002-12-15 | Fidia Advanced Biopolymers Srl | N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung |
ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
AU1979201A (en) | 1999-12-09 | 2001-06-18 | Bio Syntech Canada Inc | Mineral-polymer hybrid composition |
AU2001265400A1 (en) | 2000-07-28 | 2002-02-13 | Anika Therapeutics, Inc. | Bioabsorbable composites of derivatized hyaluronic acid |
IT1317359B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e |
IT1317358B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Derivati cross-linkati dell'acido ialuronico. |
WO2002068383A2 (en) | 2001-02-22 | 2002-09-06 | Anika Therapeutics, Inc. | Thiol-modified hyaluronan |
US20060272221A1 (en) | 2001-11-29 | 2006-12-07 | Treibacher Schleifmittel Gmbh | Al2O3 and ZrO2 based abrasive grain, method for the production and use thereof |
DE60323943D1 (de) | 2002-02-21 | 2008-11-20 | Encelle Inc | Immobilisierte bioaktive hydrogel matrizen für oberflächenbeschichtungen |
ITPD20020064A1 (it) | 2002-03-12 | 2003-09-12 | Fidia Advanced Biopolymers Srl | Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem |
WO2004000374A1 (en) | 2002-06-19 | 2003-12-31 | Dr. H.C. Robert Mathys Stiftung | Hydraulic cement based on calcium phosphate for surgical use |
US8455458B2 (en) * | 2002-10-16 | 2013-06-04 | Arthrodynamic Technologies, Animal Health Division, Inc. | Composition and method for treating connective tissue damage |
DE10257554B4 (de) | 2002-12-10 | 2008-04-10 | Treibacher Schleifmittel Gmbh | Schleifkörner mit einer Ummantelung aus einem wässrigen Bindemittel und einer komplexen feinkörnigen Oxidverbindung, Verfahren zur Behandlung derartiger Schleifkörner sowie ihre Verwendung für kunstharzgebundene Schleifmittel |
DE602004017888D1 (de) | 2003-10-09 | 2009-01-02 | Robert John Petrella | Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure |
US8124120B2 (en) | 2003-12-22 | 2012-02-28 | Anika Therapeutics, Inc. | Crosslinked hyaluronic acid compositions for tissue augmentation |
WO2007070547A2 (en) | 2005-12-14 | 2007-06-21 | Anika Therapeutics, Inc. | Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
EP1891984A1 (en) | 2006-08-24 | 2008-02-27 | Graftys | Macroporous and highly resorbable apatitic calcium-phosphate cement |
IT1393419B1 (it) | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
EP2480075B1 (en) * | 2009-09-23 | 2020-07-01 | Glenpharma AB | Compositions and methods for inducing or enhancing connective tissue repair |
CN103841927A (zh) | 2011-06-09 | 2014-06-04 | 齐默尔膝部创造物公司 | 用于软骨下关节修复的器械和装置 |
RS58902B1 (sr) | 2012-03-22 | 2019-08-30 | Trb Chemedica Int S A | Postupak za obnavljanje ligamenta ili tetive |
CN112999245A (zh) * | 2012-09-26 | 2021-06-22 | 骨治疗公司 | 包含溶剂/去污剂处理过的血浆(s/d血浆)的制剂及其用途 |
ES2904359T3 (es) * | 2014-02-20 | 2022-04-04 | Ortho Regenerative Tech Inc | Composiciones poliméricas liofilizadas para mezclar con plasma rico en plaquetas para formar implantes para la reparación de tejidos y/o composiciones para inyecciones terapéuticas intraarticulares |
-
2017
- 2017-04-26 EP EP17723815.1A patent/EP3448394B1/en active Active
- 2017-04-26 RU RU2018141386A patent/RU2018141386A/ru unknown
- 2017-04-26 CN CN201780039455.6A patent/CN109562124A/zh active Pending
- 2017-04-26 US US15/497,577 patent/US10441677B2/en active Active
- 2017-04-26 SG SG10201913342UA patent/SG10201913342UA/en unknown
- 2017-04-26 WO PCT/US2017/029635 patent/WO2017189723A1/en active Application Filing
- 2017-04-26 JP JP2019508158A patent/JP6826657B2/ja active Active
- 2017-04-26 SG SG11201809197XA patent/SG11201809197XA/en unknown
- 2017-04-26 NZ NZ747413A patent/NZ747413A/en unknown
- 2017-04-26 CA CA3021764A patent/CA3021764C/en active Active
- 2017-04-26 MX MX2018012964A patent/MX2018012964A/es active IP Right Grant
- 2017-04-26 KR KR1020187033872A patent/KR20190009303A/ko not_active IP Right Cessation
- 2017-04-26 AU AU2017257956A patent/AU2017257956B2/en active Active
- 2017-04-27 TW TW106114071A patent/TWI755392B/zh active
- 2017-04-27 TW TW109130386A patent/TW202114712A/zh unknown
-
2018
- 2018-10-22 IL IL262507A patent/IL262507B/en active IP Right Grant
- 2018-10-25 ZA ZA2018/07136A patent/ZA201807136B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3448394B1 (en) | 2023-09-13 |
US20170326271A1 (en) | 2017-11-16 |
JP2019516784A (ja) | 2019-06-20 |
NZ747413A (en) | 2020-09-25 |
AU2017257956B2 (en) | 2019-11-07 |
US10441677B2 (en) | 2019-10-15 |
RU2018141386A3 (es) | 2020-05-27 |
SG11201809197XA (en) | 2018-11-29 |
CA3021764A1 (en) | 2017-11-02 |
IL262507A (en) | 2018-12-31 |
AU2017257956A1 (en) | 2018-11-15 |
CA3021764C (en) | 2021-01-19 |
TWI755392B (zh) | 2022-02-21 |
WO2017189723A1 (en) | 2017-11-02 |
KR20190009303A (ko) | 2019-01-28 |
ZA201807136B (en) | 2021-05-26 |
EP3448394C0 (en) | 2023-09-13 |
CN109562124A (zh) | 2019-04-02 |
EP3448394A1 (en) | 2019-03-06 |
TW202114712A (zh) | 2021-04-16 |
JP6826657B2 (ja) | 2021-02-03 |
IL262507B (en) | 2020-10-29 |
RU2018141386A (ru) | 2020-05-27 |
WO2017189723A9 (en) | 2018-06-28 |
SG10201913342UA (en) | 2020-03-30 |
TW201739457A (zh) | 2017-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2692773T3 (es) | Tratamientos para la fibrosis | |
BR112017016772A2 (pt) | bactérias probióticas recombinantes para uso no tratamento de uma disfunção inflamatória da pele e método para tratá-la | |
MX2019009753A (es) | Composicion y metodos para prevenir lesion por radiacion y promover la regeneracion de tejidos. | |
NZ729417A (en) | Compositions and methods for enhancing healing and regeneration of bone and soft tissue | |
PH12019550265A1 (en) | Composition comprising mannose oligosaccharide and process for making same and use thereof | |
ZA202002779B (en) | Dantrolene prodrugs and methods of their use | |
ZA201906100B (en) | Combination of a ppar agonist with a fxr agonist | |
PH12018502161A1 (en) | Methods of treatment for cholestatic and fibrotic diseases | |
MX2020003762A (es) | Composiciones cosmeticas y metodo para tratar la piel. | |
MX366410B (es) | Composiciones y metodos para tratamiento y reparacion de tendones. | |
NZ721835A (en) | An osseointegrable device | |
MY177827A (en) | Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders | |
MX2022014763A (es) | Composiciones de grapiprant y metodos para usar las mismas. | |
AR113514A1 (es) | Composiciones y métodos para mejorar la utilización del fósforo y el calcio en la dieta de los animales | |
TW201613569A (en) | Composition consisting of kukoamine A and/or kukoamine B and method of using thereof | |
BR112017014552A2 (pt) | ?análogo de calcitonina, e, método para produzir uma diminuição nos triglicerídeos no fígado/redução de acúmulo de gordura no fígado? | |
CL2018001104A1 (es) | Composición para el cuidado de la piel y procedimiento asociado. | |
MX2018012964A (es) | Métodos y composiciones de uso para el tratamiento de la degeneración de tendón. | |
ECSP17021138A (es) | Compuestos de dipeptidil-cetoamida y su uso para el tratamiento y/o la prevención de la acumulación de grasa | |
GB2550750A (en) | Anthelmintic compounds | |
BR112016016842A2 (pt) | Composição compreendendo um herbicida seletivo e um extrato de algas, uso de um extrato de algas para desintoxicar plantas submetidas ao tratamento com um herbicida seletivo | |
MX2019004179A (es) | Composiciones de apilimod y metodos para utilizar las mismas en el tratamiento de la enfermedad de alzheimer. | |
GEP20207145B (en) | Combination of trazodone and gabapentin for the treatmen | |
NZ725354A (en) | Transdermal formulations of pergolide and uses thereof | |
WO2015200601A3 (en) | Lymphangiogenesis inhibitors for cancer and for graft survival |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |